证券记录 · 已归档季度
AZTA
Azenta, Inc. · Healthcare · Medical - Instruments & Supplies
16被追踪持有人
-1Δ持有人
19.69M持有股份
$565.39M报告持仓市值
+0新建仓位
−1清仓
动量输入（同类管理人）：
持有人广度 -5.9% ·
股份流向 -7.4% ·
净新建仓位 -6.2%
· 公式
广泛减持：持股数量下降，持有人数量减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | +1 | 120.54K | $3.93M | +1 | n/a |
| Q2 2026 | 95 | +4 | 31.71M | $809.28M | +12 | −7 |
| Q1 2026 | 93 | -11 | 30.54M | $644.99M | +6 | −17 |
| Q4 2025 | 103 | -1 | 32.89M | $1.09B | +1 | −2 |
| Q3 2025 | 16 | -1 | 19.69M | $565.39M | n/a | −1 |
| Q2 2025 | 14 | 0 | 18.89M | $581.53M | +1 | −1 |
| Q1 2025 | 11 | 0 | 5.08M | $176.05M | +1 | −1 |
| Q4 2024 | 11 | +1 | 5.23M | $261.74M | +1 | n/a |
| Q3 2024 | 9 | +1 | 2.97M | $143.74M | +1 | n/a |
| Q2 2024 | 8 | n/a | 3.27M | $172.22M | n/a | n/a |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (被动) | 6.90M | -8.0% | $198.28M | 0.0% | ▼ Trim | 2 | SEC ↗ ×17 |
| 2 | The Vanguard Group ✦ (被动) | 4.44M | -2.7% | $127.50M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 3 | State Street Global Advisors ✦ (被动) | 1.71M | -4.7% | $49.07M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 4 | Millennium Management ✦ | 1.70M | +41.6% | $48.78M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 5 | Geode Capital Management ✦ (被动) | 1.02M | -4.0% | $29.34M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 6 | JPMorgan Chase ✦ | 946.63K | n/a | $27.19M | 0.0% | n/c | 1 | SEC ↗ ×8 |
| 7 | Morgan Stanley ✦ | 941.36K | n/a | $27.04M | 0.0% | n/c | 1 | SEC ↗ ×9 |
| 8 | Fisher Asset Management ✦ | 586.29K | -7.6% | $16.84M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 9 | Gotham Asset Management ✦ | 532.30K | +6.2% | $15.29M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 10 | Goldman Sachs Group ✦ | 477.39K | n/a | $13.71M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 11 | Citadel Advisors ✦ | 160.71K | -84.8% | $4.62M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 12 | D. E. Shaw & Co. ✦ | 136.76K | -27.3% | $3.93M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 13 | AQR Capital Management ✦ | 63.20K | +182.4% | $1.78M | 0.0% | ▲ Add | 2 | SEC ↗ ×6 |
| 14 | T. Rowe Price ✦ | 39.13K | +7.3% | $1.12M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 15 | Two Sigma Investments ✦ | 19.60K | +168.2% | $562,912 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 16 | Fidelity (FMR) ✦ | 12.16K | -13.3% | $349,198 | 0.0% | ▼ Trim | 2 | SEC ↗ ×3 |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| Marshall Wace | $9.39M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 256 持有人, 52.74M 股份, $1.06B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据